Startup Stage: Company - 2022, Luxembourg ⎥ TRL8 / CRL7

Value Proposition: A biotech platform to help healthcare industry detect respiratory hazards early by using a patented in vitro lung model with >95% specificity and no animal testing

Product: Bio + AI

Market: Health

IP: License ⎪ 2 Patents

Founders (ext.): CEO, Arno Gutleb│COO, Asier Sesma│CSO, Sabina Burla

Contact (int.): Ventures, Alex Godlewski

Revenue: First revenue - Pharma

Funding: Seed (Expon Capital, Angels, Fit 4 Start) │ ~€1M raised in total